Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - IDSA Updated Covid-19 Guideline now supports the use of convalescent plasma in ambulatory patients with mild to moderate COVID-19 at high risk for progression to severe disease.

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

IDSA Updated Covid-19 Guideline now supports the use of convalescent plasma in ambulatory patients with mild to moderate COVID-19 at high risk for progression to severe disease.

Zouhair Souissi

9 février 2022

IDSA Guidelines on the Treatment and Management of Patients with COVID-19 – Infectious Diseases Society of America Related: [Preprint] RCT: In symptomatic adults above 18 years positive for SARS-CoV-2, early outpatient treatment with high-titer convalescent plasma significantly reduced hospitalizations. Commentary on Twitter Update Alert: Revised recommendation on the use of #convalescentplasma in ambulatory patients […]

The post IDSA Updated Covid-19 Guideline now supports the use of convalescent plasma in ambulatory patients with mild to moderate COVID-19 at high risk for progression to severe disease. appeared first on Links Medicus.

Lu 495 fois